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The important uropathogen Proteus mirabilis encodes a record number of
chaperone/usher-pathway adhesive fimbriae. Such fimbriae, which are used for
adhesion to cell surfaces/tissues and for biofilm formation, are typically
important virulence factors in bacterial pathogenesis. Here, the structures of the
receptor-binding domains of the tip-located two-domain adhesins UcaD (1.5 A˚
resolution) and AtfE (1.58 A˚ resolution) from two P. mirabilis fimbriae (UCA/
NAFand ATF) are presented. The structures of UcaD and AtfE are both similar
to the F17G type of tip-located fimbrial receptor-binding domains, and the
structures are very similar despite having only limited sequence similarity. These
structures represent an important step towards a molecular-level understanding
of P. mirabilis fimbrial adhesins and their roles in the complex pathogenesis of
urinary-tract infections.
1. Introduction
The urinary tract is a common target for bacterial infections.
Urinary-tract infections (UTIs) are clinically categorized as
uncomplicated or complicated. Uncomplicated UTIs occur in
individuals that are otherwise healthy, with uropathogenic
Escherichia coli (UPEC) being the main causative agent.
Complicated UTIs affect patients with underlying difficulties
such as indwelling catheters. Proteus mirabilis, a Gram-
negative bacterium famous for its ability to swarm across agar
surfaces, is a major player in causing catheter-associated UTIs
(CAUTIs; Nielubowicz & Mobley, 2010) and complicated
UTIs, including pyelonephritis, bacteraemia and urolithiasis
(Rocha et al., 2007). P. mirabilis utilizes a multitude of viru-
lence factors, including urease, flagella and fimbriae, to
establish and promote infection (Schaffer & Pearson, 2015).
Fimbriae are important virulence factors that are used for
adhesion to cell surfaces/tissues and for biofilm formation
(Schaffer & Pearson, 2015). 17 fimbrial gene clusters (FGCs)
encoding chaperone/usher (CU) fimbrial assembly machi-
neries and associated fimbrial subunits have been identified in
the genome sequence of P. mirabilis HI4320, a representative
strain isolated from the urine of an elderly, long-term (30 d)
catheterized patient (Pearson et al., 2008).
The CU pathway is commonly used by pathogenic Gram-
negative bacteria to assemble Ig-like protein subunits (‘pilins’)
into fimbriae (Geibel & Waksman, 2014; Zav’yalov et al.,
2010). In CU-mediated assembly, a periplasmic chaperone
assists the folding of the incomplete immunoglobulin (Ig)-like
pilin subunits and delivers them in a high-energy intermediate
form (Zavialov et al., 2003) to the outer membrane usher,
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where assembly and secretion to the cell surface takes place.
CU fimbriae can be classified into two main groups. Fimbrial
monoadhesins display a specialized two-domain adhesin
(TDA) subunit at the tip of rod-like fimbriae. TDAs consist of
an N-terminal domain (NTD) that is responsible for high-
affinity binding to receptors (usually carbohydrates), joined
through a short linker to a C-terminal pilin domain. Fimbrial
polyadhesins are instead typically thin and flexible structures
in which each fimbrial subunit can bind with weak affinity to
one or two distinct host cell receptors. Multivalent binding of
polyadhesins to their receptors provides tight binding via a
considerable avidity effect. 14 of the 17 P. mirabilis FGCs
encode a putative TDA and hence are likely to produce
fimbrial monoadhesins if expressed. Two of the most studied
of these are uroepithelial cell adhesin (UCA), also known as
non-agglutinating fimbriae (NAF), and ambient temperature
fimbriae (ATF).
UCA/NAF was first identified in 1986 (Wray et al., 1986).
The major adherence component was purified from the outer
membrane fraction of a P. mirabilis preparation incubated
with shed human uroepithelial cells. The isolated 17.5 kDa
protein subunit was found to self-assemble as long and flexible
rods of 4–6 nm in width. The uca FGC, which is homologous to
the FGCs encoding the F17 family of fimbriae in UPEC (Cook
et al., 1995), encodes a major fimbrial subunit (UcaA), a
chaperone (UcaB), an usher (UcaC), a TDA (UcaD) and a
transcriptional regulator (UcaJ). An isogenic ucaA mutant
was significantly impaired both in adherence to exfoliated
human uroepithelial cells as well as in kidney colonization
(Pellegrino et al., 2013). UCA fimbriae were also found to
contribute to fitness in a CAUTI mouse model (Armbruster et
al., 2017). Taken together, these findings suggest that UCA
fimbriae are important for the establishment and progression
of P. mirabilis UTI.
ATF are expressed from the atf FGC, which contains six
genes, atfABCDEJ, encoding a major structural subunit
(AtfA), a chaperone (AtfB), an usher (AtfC), a minor subunit
(AtfD), a TDA (AtfE) and a transcriptional regulator (AtfJ)
regulating ATF expression (Armbruster et al., 2018). An
atfABC mutant was compared with the wild type in both
independent-challenge and co-challenge experiments in an
ascending UTI mouse model, and no obvious difference was
found in bacterial counts in either bladder or kidneys 7 d post-
inoculation (Zunino et al., 2000). This, together with the fact
that ATF are maximally expressed in static culture at 23C,
suggests that rather than contributing to virulence, ATF play a
role in environments external to a mammalian host (Zunino
et al., 2000). However, other studies have pointed to links
between the production of ATF and MR/P fimbriae, which are
a major contributor to bladder infection (Armbruster et al.,
2018), suggesting that ATF somehow also contribute to UTI.
For instance, when ATF was discovered in 1994, AtfA was
found to co-purify with MR/P fimbriae even when cells were
grown in conditions favouring the expression of ATF (Massad
et al., 1994). An isogenic mrpA mutant unable to express
MR/P fimbriae was required in order to isolate ATF (Massad
et al., 1994). A later study compared bladder colonization in
P. mirabilis mutant strains engineered with constitutive or no
MR/P fimbrial production (locked ON or OFF; Jansen et al.,
2004). Strikingly, AtfA was found on the surface of bacteria
colonizing mouse bladders 2 d after inoculation with the MR/P
OFF strain, despite the unfavourable expression temperature.
The MR/P OFF strain adhered to lamina propria underlying
exfoliated uroepithelium, a pattern that was drastically
different compared with MR/P ON and wild-type P. mirabilis,
which both preferentially target intact uroepithelium. Also,
the atfABCmutant was found to be the most affected among a
collection of isogenic fimbrial mutant strains (including wild
type, mrpA, pmfA and ucaA) in terms of biofilm formation
and the ability to swarm across latex catheter segments
(Scavone et al., 2016). Therefore, the contribution of ATF to
P. mirabilis pathogenesis might have been underestimated.
Here, we present the first two atomic structures of TDA
receptor-binding domains from P. mirabilis fimbriae: UcaD
and AtfE. Our work provides an important stepping stone
towards a molecular-level understanding of P. mirabilis
fimbrial adhesins and their roles in the complex pathogenesis
of this important uropathogen.
2. Materials and methods
2.1. Construct design and cloning
Since pilin domains are very unstable and tend to aggregate
in the absence of a chaperone, a convenient way to obtain
material for structural and functional studies of TDAs is to
express the receptor-binding NTDs by themselves (see, for
example, Buts et al., 2003; Bouckaert et al., 2005). Constructs
encoding the NTDs of the AtfE and UcaD TDAs (AtfEntd and
UcaDntd, respectively) were designed with the N-terminal
signal peptides intact to ensure correct maturation following
translocation to the periplasm. Initial putative domain borders
were assigned based on multiple sequence alignment with pilin
domains in combination with threading using Phyre2 (Kelley
et al., 2015). In order to optimize the constructs for protein
expression, constructs with different numbers of residues
included at the C-terminus were screened for soluble
expression at the Protein Science Facility (PSF), Karo-
linska Institute, Stockholm, Sweden (http://ki.se/en/mbb/
protein-science-facility) using a ligation-free cloning
methodology (Aslanidis & de Jong, 1990). DNA encoding
target constructs was PCR-amplified from P. mirabilisHI4320
genomic DNA. T4 DNA polymerase was used to produce
complementary ssDNA overhangs on the PCR product and
plasmid (pNIC-CH2). The expression plasmid introduces an
additional alanine between the target DNA insertion site and
the C-terminal His6 tag encoded by the plasmid. Sequence-
verified constructs were tested for small-scale expression using
the E. coli BL21(DE3) R3 pRARE2 phage-resistant strain.
The results of the PSF construct screening are shown in
Table 1. Protein from two PSF constructs for UcaD
(psfUCAD-c002 and psfUCAD-c004) was used for crystal-
lization. Since the AtfE PSF constructs provided only low-
yield large-scale expression, the DNA encoding AtfE residues
1–210 and the C-terminal His6 tag was PCR-amplified from
research papers
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the corresponding PSF plasmid (psfATFE-c003; Table 1) and
recloned into the pEXP5-CT/TOPO vector (Invitrogen, USA)
for verification of the sequence. The verified plasmid was
transformed into SHuffle Express T7 competent E. coli (K12
strain; New England BioLabs, USA) for expression, since the
SHuffle strain provided higher expression levels in small-scale
tests (10 ml LB culture) compared with BL21 strains. For
simplicity, all constructs used for crystallization will be desig-
nated by the C-terminal end residue in the following.
2.2. Protein production and purification
For UcaDntd, two constructs were used for structure deter-
mination. The UcaD211 and UcaD217 constructs were
expressed in the E. coli BL21(DE3) R3 pRARE2 phage-
resistant strain by inoculating fresh lysogeny broth (LB)
containing 50 mg ml1 kanamycin with a 1% volume of over-
night pre-culture. The cells were incubated at 37C with
shaking until the OD600 reached 0.9. Isopropyl -d-1-thioga-
lactopyranoside (IPTG) was added to a final concentration of
0.5 mM. Induced expression was carried out at 18C over-
night.
For AtfEntd, the AtfE210 construct was expressed in SHuffle
Express T7 competent E. coli cells (New England Biolabs,
USA) by inoculating fresh LB medium containing 100 mg ml1
ampicillin with a 1% volume of overnight pre-culture. The
cells were incubated at 30C (the recommended temperature
for expression in SHuffle Express cells) with shaking until the
OD600 reached 1.2. The cells were then transferred to 4
C for
20 min to cool before IPTG was added to a final concentration
of 0.5 mM and expression continued at 18C overnight.
The cells were harvested by centrifugation at 7500g at 4C
for 15 min. The harvested cells were homogenized in solubi-
lization buffer [100 mM NaCl, 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) pH 7.5, 5% glycerol
for UcaDntd and 500 mM NaCl, 50 mM HEPES pH 7.8, 5 mM
dithiothreitol (DTT) for AtfEntd], to which one tablet of
cOmplete protease-inhibitor cocktail (Roche) and 10 mg ml1
DNase (from bovine pancreas; Sigma–Aldrich) were added.
The cell suspension was stirred at 4C for 45 min before
passage through a cell disruptor (Constant Systems, UK) twice
at 207 MPa pressure to ensure adequate lysis. The cell lysate
was centrifuged at 30 500g for 30 min at 4C and the super-
natant was collected.
Soluble fractions of both UcaDntd and AtfEntd were first
purified by nickel-immobilized metal-affinity chromatography
(Ni-IMAC). The imidazole concentration in the soluble frac-
tion was adjusted to 5 and 20 mM, respectively, before binding
to equilibrated Ni Sepharose 6 Fast Flow (GE Healthcare)
resin. Impurities and target proteins were separated by adding
increasing concentrations of imidazole to the buffer. Unbound
protein and most impurities were washed away with 50 mM
imidazole. UcaDntd and AtfEntd were eluted with 300 and
500 mM imidazole, respectively. UcaDntd was further purified
using a Superdex 75 16/60 column (GE Healthcare) equili-
brated with the homogenization buffer.
Ni-IMAC-eluted AtfEntd was buffer-exchanged into
2-morpholinoethanesulfonic acid (MES) buffer (50 mM MES
pH 5.6, 10 mM -mercaptoethanol). A precipitate mainly
consisting of impurities caused by the shift from pH 7.8 to 5.6
was removed by centrifugation at 6500g using a desktop
centrifuge (Heraeus Multifuge 3SR with swing-out rotor
75006441). The protein was further purified using a HiTrap
Heparin column (GE Healthcare), a two-mode chromato-
graphy agent with both affinity and cation-exchange capacity.
AtfEntd was eluted with a gradient of NaCl in 50 mMMES pH
5.6, 10 mM -mercaptoethanol. Typically, AtfEntd eluted at
600 mM NaCl.
2.3. Crystallization
Crystallization was carried out by sitting-drop vapour
diffusion using a Mosquito Crystal crystallization robot (TTP
Labtech, England). A typical crystallization drop was
prepared by mixing protein and reservoir solutions in a 1:1
ratio to give a final volume of 300 nl. Seed stocks were
prepared by diluting a drop containing crystalline material
660-fold by volume with the corresponding reservoir. Seeding
was performed on the dispensed plate by adding 30 nl seed
stock to each 300 nl drop.
Diffraction-quality UcaD211 crystals appeared overnight at
293 K after the seeding of drops with protein at 20 mg ml1
mixed with 0.005 M CoCl2, 1M HEPES pH 7.5, 10–15% PEG
3350. Initial crystalline material grown in 0.1 M trisodium
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Table 1
Constructs and Protein Science Facility screening results.
FGC TDA gene Construct End residue
Soluble small-scale
expression† Comments
fim4/uca/naf PMI0533 psfUCAD-c001 Asn208 1
psfUCAD-c002 Arg211 3 Purified protein: UcaD(21–211)-AHHHHHH
psfUCAD-c003 Val214 3
psfUCAD-c004 Gln217 3 Purified protein: UcaD(21–217)-AHHHHHH
fim13/atf PMI2732 psfATFE-c001 Asn205 2
psfATFE-c002 Thr208 2
psfATFE-c003 Thr210 3 Re-cloned into the pEXP5-CT/TOPO (Invitrogen) vector and transformed
into E. coli SHuffle Express to produce AtfE(25–210)-AHHHHHH
psfATFE-c004 Arg214 3
† Amounts of both totally expressed and purified protein were analysed by SDS–PAGE. Based on the SDS–PAGE results, the soluble expression levels were scored as 4, dominating
band of target protein; 3, band much stronger than background; 2, band equal to/stronger than background; 1, band weaker than background; 0, no detected protein.
citrate pH 5.5, 20% PEG 3000 was used as a seed stock. The
presence of cobalt was required for crystal formation. An
iodine derivative of UcaD211 for single anomalous dispersion
(SAD) phasing was prepared by soaking the crystals in
cryoprotectant containing NaI (0.005 M CoCl2, 0.1M HEPES
pH 7.5, 15% PEG 3350, 20% glycerol, 1M NaI) for 45 min
before flash-cooling in liquid nitrogen.
UcaD217 crystals for native data collection were obtained
using protein at 16 mg ml1 mixed with 2M ammonium
sulfate, 0.1M bis-Tris pH 5.5. Diffraction-quality crystals
appeared in a week at 293 K after seeding with seed stock
from similar conditions. Crystals were cryoprotected with
sucrose (by dropping a solid grain of sucrose into the crys-
tallization drop) before flash-cooling with liquid nitrogen.
AtfE210 crystals for native data collection were obtained
using protein at 5 mg ml1 in 0.8M NaH2PO4, 0.8 M KH2PO4,
0.1M HEPES pH 7.5. Diffraction-quality crystals appeared at
293 K 2–4 weeks after seeding with
initial crystalline material obtained
from similar conditions with 9 mg ml1
AtfE210. The crystals were cryopro-
tected with 18% glycerol before flash-
cooling with liquid nitrogen. Crystals for
iodine SAD phasing were grown in
0.7M NaH2PO4, 0.7M KH2PO4, 0.1 M
sodium acetate pH 5.0 and were then
soaked in 1M NaI, 0.65 M NaH2PO4,
0.65 M KH2PO4, 0.1 M sodium acetate
pH 5.0, 23% glycerol for 7 h prior to
flash-cooling in liquid nitrogen.
2.4. Data collection and structure
determination
Data collection was performed at
100 K at the European Synchrotron
Radiation Facility (ESRF), Grenoble,
France or at Diamond Light Source
(DLS), UK. Diffraction data were
processed using XDS (Kabsch, 2010)
and scaled and merged using the CCP4
(Winn et al., 2011) program AIMLESS
(Evans & Murshudov, 2013). Experi-
mental phasing and initial automatic
model building was performed with
PHENIX (Adams et al., 2010) using the
phenix.autosol (Terwilliger et al., 2009)
and phenix.autobuild (Terwilliger et al.,
2008) modules. Phaser (McCoy et al.,
2007) was used for molecular replace-
ment. Refinement was carried out using
phenix.refine (Afonine et al., 2012).
Torsional NCS restraints were applied
during the refinement of structures with
more than one protomer in the asym-
metric unit (UcaD217 and AtfE210). All
structures were modelled with isotropic
temperature factors and TLS. Model building was performed
using Coot (Emsley et al., 2010). Structure validation was
carried out using the tools available in phenix.refine (Afonine
et al., 2012) and Coot (Emsley et al., 2010). Resolution cutoffs
were based on CC1/2 (Karplus & Diederichs, 2012) and the
completeness of the data. Native data-collection and refine-
ment statistics are listed in Table 2.
UcaD211 crystallized in two crystal forms. Iodine SAD data
for UcaD211 were collected to 2.5 A˚ resolution on beamline
I02 at DLS from a single crystal in space group P4322 with two
molecules in the asymmetric unit. Native UcaD211 data were
collected to 1.7 A˚ resolution on beamline ID23-2 at the ESRF
from a single crystal in space group I4122 with one molecule in
the asymmetric unit. Native UcaD217 data were collected to
1.5 A˚ resolution on beamline ID23-2 at the ESRF from a
single crystal in space group P1 with two molecules in the
asymmetric unit. The initial SAD-phased UcaD211 model was
research papers
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Table 2
Native data-collection and refinement statistics.
AtfE210 UcaD211 UcaD217
Data collection
Space group C2 I4122 P1
a, b, c (A˚) 74.91, 103.79, 67.76 73.35, 73.35, 153.11 30.47, 49.83, 61.83
, ,  () 90, 95.8, 90 90, 90, 90 86.45, 74.51, 75.52
Molecules in asymmetric unit 2 1 2
Wavelength (A˚) 0.968 0.873 0.873
Resolution (A˚) 33.7–1.58 (1.637–1.58) 41.89–1.70 (1.76–1.70) 37.40–1.50 (1.554–1.50)
Total reflections 502379 (50277) 170475 (16225) 192740 (18129)
Unique reflections 68833 (6417) 23405 (2269) 52581 (5178)
Multiplicity 7.3 (7.4) 7.3 (7.2) 3.7 (3.5)
Completeness (%) 97.25 (91.39) 99.75 (99.21) 96.61 (94.79)
hI/(I)i 9.31 (0.82) 10.18 (1.20) 7.08 (1.30)
Wilson B factor (A˚2) 17.96 22.31 11.97
Rmerge† 0.134 (2.10) 0.1162 (1.164) 0.1181 (0.9651)
Rmeas‡ 0.144 (2.25) 0.1251 (1.255) 0.1387 (1.14)
Rp.i.m.§ 0.05293 (0.816) 0.04577 (0.4643) 0.07172 (0.5974)
CC1/2 0.998 (0.500) 0.998 (0.699) 0.994 (0.530)
Refinement
No. of reflections in work set 65012 (6079) 22133 (2149) 49977 (4900)
No. of reflections in test set 3409 (319) 1232 (112) 2570 (266)
R} (%) 17.8 (35.0) 19.8 (34.7) 20.9 (32.5)
Rfree} (%) 20.2 (37.4) 22.0 (30.6) 23.8 (34.3)
No. of non-H atoms
Total 3276 1671 3423
Protein 2861 1514 3062
Solvent 381 155 316
Ligands 4 glycerol, 2 PO4
3 2 Co2+ 9 SO4
2
R.m.s. deviations
Bonds (A˚) 0.007 0.005 0.007
Angles () 1.29 1.09 1.10
Ramachandran statistics
Favoured (%) 98.29 98.42 97.90
Allowed (%) 1.71 1.58 2.10
Outliers (%) 0.00 0.00 0.00
Rotamer outliers (%) 1.26 0.00 0.30
Clashscore 2.79 3.30 1.77
Average B factor (A˚2)
Overall 27.1 30.81 16.31
Protein 25.8 30.26 15.30
Ligands 48.8 47.04 42.94
Solvent 35.0 35.94 22.27
PDB code 6h1q 6h1x 6h2l
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Rmeas =
P
hklfNðhklÞ=½NðhklÞ  1g1=2P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. § Rp.i.m. =
P
hklf1=½NðhklÞ  1g1=2
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ.
} R =
P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj calculated for a final model refined against all of the data. Rfree is calculated
for a test set comprising 5% of the reflections.
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Figure 1
Three-dimensional crystal structure of UcaDntd. (a) Cartoon representa-
tion of UcaDntd. Secondary-structure elements are labelled A–G from the
N-terminus to the C-terminus. -Strands forming a -sheet are in the
same colour: -strands A1/2, G1/2, F1/2, C and D2 are coloured blue,
B1/2, E and D1 are coloured green and C0 and C0 0 are coloured grey.
Helices are coloured grey. Coils are coloured pale yellow. (b) Topology
diagram of UcaDntd with the secondary-structure elements coloured in
the same way as in (a).
Figure 2
Structural superposition of the NTDs of (a) UcaD and UclD, (b) UcaD
and F17cG, and (c) UcaD and AtfE shown as stereoviews. All structures
are shown in carton representation and are superimposed using UcaDntd
as the reference. Colouring is based on sequence similarity. UcaD and
UclD are shown in deep and light blue, respectively, F17cG is shown in
gold and AtfE is shown in pink.
iteratively remodelled and refined against the native UcaD211
data. The resulting model was used as a search model to solve
the UcaD217 structure by molecular replacement.
AtfE210 crystallized in one crystal form belonging to space
group C2 with two molecules in the asymmetric unit. Native
AtfE210 data were collected to 1.6 A˚ resolution from a single
crystal on beamline ID30A-3 at the ESRF. Iodine SAD data
were collected to 2.5 A˚ resolution from four AtfE210 deriva-
tive crystals on beamline ID23-1 at the ESRF. The initial
SAD-phased model was iteratively remodelled and refined
against the native data.
2.5. Other software
Structures were superimposed and structure-based
sequence alignments were obtained using Chimera Match-
Maker (Meng et al., 2006). Multiple sequence alignment was
performed with COBALT (Papadopoulos & Agarwala, 2007)
and was visualized using ESPript 3.0 (Robert & Gouet, 2014).
Graphical representations of protein structures were prepared
using UCSF Chimera (Pettersen et al., 2004).
3. Results and discussion
Both UcaDntd and AtfEntd were expressed with their native
N-terminal signal peptides to ensure correct maturation
following translocation to the periplasm. In all cases the first
residue visible in the electron-density maps corresponded to
the first residue after the predicted signal sequence. The start
and end points of the crystallized proteins are listed in Table 1.
3.1. Structure of UcaDntd
Since no structural model with sufficient sequence identity
was available in the Protein Data Bank (PDB) at the time,
de novo SAD phasing using a sodium iodide derivative of
UcaD211 that diffracted to 2.5 A˚ resolution was used to obtain
initial phases. Similar to other TDA receptor-binding domains,
UcaD211 adopts an Ig-like Greek-key fold. However, the
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Figure 3
Structure-based multiple sequence alignment of the NTDs of AtfE, F17aG, F17bG, F17cG, UclD and UcaD. Structures were superimposed with UcaDntd
to generate the alignment. Residues are numbered according to their position in the native sequences. Identical residues are highlighted with red shading
and white text, and similar residues with a blue frame and red text. The top and bottom secondary-structure depictions refer to AtfEntd and UcaDntd
respectively. Residues that form side-chain interactions with bound GlcNAc in F17aG, F17bG and F17cG are marked with red stars.
C-terminal His tag of UcaD211 takes on part of the role of the
final (G) strand in the fold (Supplementary Fig. S1),
suggesting that the domain border was trimmed too short and
that the NTD in UcaD211 is incomplete. Indeed, in the longer
UcaD217 construct the last six residues replace the His tag
from the shorter construct to form the last -strand and
complete the Ig-like fold (Fig. 1). In the UcaD211 structure,
two cobalt-coordination sites were found in each asymmetric
unit. One site is formed by His48 and two histidine residues
from the His tag (His216 and His218). The second site is
composed entirely of residues from the His tag: His213 and
His215 in one protomer and His217 from the symmetry-
related protomer (Supplementary Fig. S1). This explains why
cobalt ions were essential for the crystallization of the short
construct.
The UcaD211 and UcaD217 structures are very similar, with
r.m.s.d.s of 0.594 A˚ for 176 equivalent C atoms in UcaD211
and chain A of UcaD217, and 0.763 A˚ for 179 equivalent C

atoms in UcaD211 and chain B of UcaD217. The largest
differences are found in the C-terminal region, as expected, as
well as in the six first residues (21–26) and in the BC loop,
which interacts with the N-terminal region. These latter
differences were initially attributed to differences in crystal
packing (the N-terminal region is involved in crystal packing
between the two protomers in the asymmetric unit in the
UcaD217 structure), but are likely to be caused by an unfor-
tunate accidental Tyr–His mutation at position 25 in the
UcaD217 construct that was discovered in the final stages of
refinement and was confirmed by re-
sequencing of the construct.
UcaDntd forms an elongated
(approximate dimensions 60  35 
30 A˚) -sandwich with the N- and
C-termini at opposite ends of the
structure (Fig. 1a). Based on the struc-
tures of other TDAs, the domain is
expected to be oriented with its longest
dimension along the direction of the
fimbrial axis when incorporated into
UCA fimbriae. Strands A1/2, G1/2,
F1/2, C and D2 form one sheet of the
sandwich, while strands B1/2, D1 and E
form the second (referred to as the
BED sheet below). The C–D and D–E
loops (C0, C00; D0, 2) form a flap
covering the BED sheet of the -sand-
wich (Fig. 1).
A DALI search (Holm & Sander,
1995) for structural homologues of
UcaDntd identified the NTDs of F17G
and F17G-like fimbrial adhesins (F17cG
and UclD, respectively) as the top-
scoring hits (Figs. 2a and 2b, Table 3).
UcaDntd shares 84% sequence identity
with E. coli UclDntd (Fig. 3) and hence
might be expected to recognize a similar
receptor. In contrast, the UcaDntd
sequence is only 15% identical to that of
E. coli F17cGntd.
An O-linked oligosaccharide has
been suggested as a possible UclD
receptor based on the observation that
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Figure 4
Comparison of the electrostatic surface potentials of UcaDntd (a) and F17cGntd (b). UcaDntd and
F17cGntd are shown in surface representation with positively charged regions in blue, negatively
charged regions in red and uncharged regions in white. The two structures are shown in the same
orientation. (a) Residues in UcaDntd forming a small pocket overlapping with the known GlcNAc-
binding pocket in F17cG are highlighted as sticks. All residues are labelled and atoms are coloured
according to element: carbon in green, oxygen in red and nitrogen in deep blue. (b) The known
binding site of F17cG is indicated with the bound GlcNAc shown in ball-and-stick representation in
pale yellow. O and N atoms are coloured in the same way as in (a).
Table 3
Top DALI hits for UcaD and AtfE.
(a) UcaD.
Protein PDB code R.m.s.d. (A˚) No. aligned Identity (%) Z
UclD 5nwp 1.0 193 84 32.1
F17c-G (GafD) 1oio 2.9 163 15 15.5
LpfD 5afo 3.1 144 11 9.8
MrkD1P 3u4k 3.7 136 13 9.0
CupB6 5cyl 3.1 146 11 8.5
(b) AtfE.
Protein PDB code R.m.s.d. (A˚) No. aligned Identity (%) Z
UclD 5nwp 2.2 163 19 17.5
F17c-G (GafD) 1oio 3.1 157 13 13.7
LpfD 5afo 3.1 138 12 9.9
MrkD1P 3u4k 3.4 134 13 8.9
CupB6 5cyl 3.3 142 15 7.5
the binding of UclD in mouse colonic sections was abolished
when pre-treating the tissue with O-glycosidase (Spaulding et
al., 2017). The region in UclD corresponding to the N-
acetylglucosamine (GlcNAc)-binding pocket in F17cG (Buts
et al., 2003; Fig. 4) was also suggested as a potential receptor-
binding site in UclD (Spaulding et al., 2017), despite none of
the residues being conserved (Fig. 3). The pocket found in this
region in UcaD (and in UclD) is smaller and less charged than
the F17cG pocket (Fig. 4). The pocket is lined with residues
(Gln63, Tyr123, Trp124, Asp140, Asn152, Thr155 and Ser157)
that could potentially hydrogen-bond to, as well as form
-stacking interactions with, a carbohydrate receptor.
However, receptor-binding pockets are found in many
different locations in fimbrial adhesins sharing the same
overall Ig-like fold (De Greve et al., 2007; Moonens et al.,
2012), although in most cases they are located in the top half
of the NTD. Hence, in the absence of firm knowledge about
the identities of the UclD and UcaD receptor(s), and given the
lack of any significant sequence similarity between UclD/
UcaD and F17cG, the prediction of a receptor-binding site
based solely on a similar fold remains speculative.
Purified UCA fimbriae have been shown to bind to asialo-
GM1, asialo-GM2 and lactosyl ceramide glycolipids in vitro
(Lee et al., 2000). However, since anti-UCA antibodies (which
would be expected to chiefly target the major subunit present
in fimbriae in huge excess over the single TDA per fimbria)
blocked binding to the glycolipids, the observed binding is
likely to be mediated by the major subunit rather than by
UcaD. Also, while asialo-GM1 is commonly found on the
surface of neuronal and immune cells, its presence on the
surface of bladder epithelial cells has not been shown, casting
doubt on the relevance of this finding for UTI.
3.2. Structure of AtfEntd
The AtfE210 structure (Fig. 5) was solved by SAD phasing
using a sodium iodide derivative. Despite the low sequence
identity between AtfEntd and UcaDntd (18%; Fig. 3), the two
structures are very similar (Fig. 2c), with an r.m.s.d. of 1.175 A˚
for 98 matched C positions. As for UcaDntd, the top DALI
hits were UclD and F17cG (Table 3). Both AtfEntd and
UcaDntd have distinct extended C
0C00 insertions in the C–D
loop compared with F17G TDAs (Figs. 1, 4 and 2c). Both
structures have an AGFC sheet made from split stands, similar
to F17G TDAs. AtfEntd has a disulfide bond between Cys67
and Cys75 linking the end of strand B to the first residue in
strand C. A conserved disulfide bond is present in F17G
NTDs, but this connects the beginning of strand C to the DE
loop. In UcaDntd there is no disulfide bond. In contrast to
F17G TDAs, both AtfEntd and UcaDntd have a cis-proline
(Pro143 in AtfE and Pro141 in UcaD) at a structurally
equivalent position right after strand D2. In UcaD (and
UclD), this proline comes right after the asparagine residue
(Asp140) in the pocket corresponding to the GlcNAc-binding
pocket in F17cG (Fig. 4). Although cis-prolines often have
specific structural and functional roles in proteins (Lorenzen et
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Figure 5
Three-dimensional crystal structure of AtfEntd. (a) Cartoon representa-
tion of AtfEntd. Secondary-structure elements are labelled A–G from the
N-terminus to the C-terminus. -Strands forming a -sheet are in the
same colour: -strands A1/2, G1/2, F1/2, C1 and D2 are coloured blue, B,
E, D1 and C2 are coloured green and C0 and C0 0 are coloured grey. Coils
are coloured pale yellow. (b) Topology diagram of AtfEntd with the
secondary-structure elements coloured in the same way as in (a). A
disulfide bond is highlighted in yellow with dashed lines indicating the
positions of the two cysteines that form a disulfide bond in AtfEntd.
al., 2005), the significance of the UcaD/AtfE cis-proline is
unclear.
Studies have suggested ATF-dependent binding to ex-
foliated bladder sections rather than to intact bladder surfaces
(Jansen et al., 2004). Such regions typically expose the barrier
layer of sulfated glycosaminoglycans (sGAGs) just below the
superficial layer of umbrella cells lining the urothelium. The
most important sGAGs in the bladder are heparan sulfate
(HS), chondroitin sulfate (CS) and dermatan sulfate (DS),
with CS located on the superficial (luminal) layer of the
urothelium, while HS is found deeper down in the urothelium,
in the basal membrane (Janssen et al., 2013). Interestingly,
during affinity chromatography of AtfE210 we noted binding of
the protein to the heparin matrix at both pH 5.5 and 8.0,
suggesting not only nonspecific charge–charge interactions but
also specific binding. Examination of the electrostatic surface
of AtfEntd reveals a distinct positively charged ridge curving
around the tip and extending approximately halfway down the
domain (Fig. 6). Two pockets are located within the borders of
the ridge. It is tempting to speculate that this feature of AtfE
might allow specific binding to sGAG structures such as, for
example, HS, explaining the preferential binding to exfoliated
bladder sections (Jansen et al., 2004).
4. Conclusion
In summary, despite their divergent sequences, both AtfEntd
and UcaDntd have similar structures. The structures, together
with information from crystallization and protein-purification
conditions, will provide the basis for future work on identi-
fying receptors and the physiological functions of ATF and
UCA.
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